84 results on '"Gupta, Amit"'
Search Results
2. Calcium Phosphate Content Does Not Affect Stone-Free Rate After Percutaneous Nephrolithotomy
3. RADICAL CYSTECTOMY AND URINARY DIVERSION LEAD TO METABOLIC ACIDOSIS AND INCREASED BONE TURNOVER WHICH PERSISTS AT LEAST ONE YEAR AFTER SURGERY: MP45-16
4. Risk of Vascular Toxicity with Platinum Based Chemotherapy in Elderly Patients with Bladder Cancer
5. Do Biomechanical Properties of Anterior Vaginal Wall Prolapse Tissue Predict Outcome of Surgical Repair?
6. American Association for the Surgery of Trauma Grade 4 Renal Injury Substratification Into Grades 4a (Low Risk) and 4b (High Risk)
7. Predictors of Cost and Clinical Outcomes of Percutaneous Nephrostolithotomy
8. Urinary Tract Infection Following Successful Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux
9. OBESITY INCREASES THE RISK OF INVASIVE PENILE CANCER: MP10-13
10. Multivariate Analysis of Factors Predicting Success With Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux
11. Outcomes of Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: A Contemporary Series From the Bladder Cancer Research Consortium
12. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases
13. Association of Tumor Necrosis With Pathological Features and Clinical Outcome in 754 Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An International Validation Study
14. pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder
15. Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers
16. CALCIUM PHOSPHATE CONTENT DOES NOT EFFECT STONE FREE RATES FOLLOWING PERCUTANEOUS NEPROLITHOTOMY (PCNL): 1889
17. RISK AND PREDICTORS OF FRACTURES AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION: 944
18. LYMPHOVASCULAR INVASION IS A PATHOLOGIC FEATURE OF BIOLOGICALLY AGGRESSIVE DISEASE IN PATIENTS WITH UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT: AN INTERNATIONAL EXTERNAL VALIDATION STUDY: 157
19. DEMOGRAPHIC AND URODYNAMIC FACTORS ASSOCIATED WITH PERSISTENT OAB AFTER PROLAPSE REPAIR: 1659
20. PREDICTORS OF COST AND CLINICAL OUTCOMES FOR PATIENTS UNDERGOING PERCUTANEOUS NEPHROSTOLITHOTOMY (PCNL): 1373
21. Natural History of Residual Fragments Following Percutaneous Nephrostolithotomy
22. Intra-Orifice Versus Hydrodistention Implantation Technique in Dextranomer/Hyaluronic Acid Injection for Vesicoureteral Reflux
23. Determinants of Quality of Life for Patients With Kidney Stones
24. PREDICTIVE VALUE OF HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR (HGF/SF) IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER: 2092
25. CYSTOCELE GRADING: DOES SUPINE EXAMINATION CORRELATE WITH STANDING CYSTOGRAPHIC FINDINGS?: 1977
26. A CONDITIONAL NOMOGRAM FOR PREDICTION OF EARLY RECURRENCE OF BLADDER CANCER AFTER RADICAL CYSTECTOMY: 1604
27. A SYSTEMATIC ANALYSIS OF THE PROGNOSTIC ABILITY OF VARIOUS NODAL CODING SCHEMES IN BLADDER CANCER PATIENTS TREATED WITH RADICAL CYSTECTOMY: 1605
28. LYMPHOVASCULAR INVASION (LVI) IS INDEPENDENTLY ASSOCIATED WITH BLADDER CANCER RECURRENCE AND SURVIVAL IN PATIENTS WITH T1 AND NEGATIVE LYMPH NODES AT RADICAL CYSTECTOMY: 1598
29. ASSESSEMENT OF THE MINIMUM NUMBER OF LYMPH NODES NEEDED AT RADICAL CYSTECTOMY IN BLADDER CANCER PATIENTS: 1599
30. NATURAL HISTORY OF RESIDUAL FRAGMENTS FOLLOWING PERCUTANEOUS NEPHROSTOLITHOTOMY: 1361
31. DOES RENAL RADIO FREQUENCY ABLATION (RFA) RESULT IN DEVELOPMENT OF POSTABLATION INFLAMMATORY RESPONSE?: 962
32. DETERMINANTS OF QUALITY OF LIFE IN PATIENTS WITH KIDNEY STONES: 471
33. IMPACT OF BODY MASS INDEX ON COST AND CLINICAL OUTCOMES FOLLOWING PERCUTANEOUS NEPHROSTOLITHOTOMY: 161
34. Nomogram for Predicting Disease Recurrence After Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
35. Clinical Outcomes Following Radical Cystectomy for Primary Nontransitional Cell Carcinoma of the Bladder Compared to Transitional Cell Carcinoma of the Bladder
36. Cancer Specific Outcomes in Patients With PT0 Disease Following Radical Cystectomy
37. LONG-TERM FOLLOWUP OF ELDERLY DONORS IN A LIVE RELATED RENAL TRANSPLANT PROGRAM
38. EXPANDING THE LIVING RELATED DONOR POOL IN RENAL TRANSPLANTATION: USE OF MARGINAL DONORS
39. EVALUATION OF THE UROLOGICAL COMPLICATIONS OF LIVING RELATED RENAL TRANSPLANTATION AT A SINGLE CENTER DURING THE LAST 10 YEARS: IMPACT OF THE DOUBLE-J STENT
40. 2023 ARE THE RIGHT MEN BEING SCREENED? TRENDS IN PSA SCREENING IN THE UNITED STATES (US)
41. EVALUATION OF THE UROLOGICAL COMPLICATIONS OF LIVING RELATED RENAL TRANSPLANTATION AT A SINGLE CENTER DURING THE LAST 10 YEARS: IMPACT OF THE DOUBLE-J**Medical Engineering Corp., New York, New York. STENT
42. 1511: Outcomes of Patients with Clinical T1 Grade 3 Bladder Urothelial Cell Bladder Carcinoma Treated with Radical Cystectomy
43. 1297: Prospective, Multi-Institutional Study of General Anesthesia Assisted Percutaneous, Computed Tomography-Guided Radiofrequency Ablation of Renal Masses: Intermediate Term Results
44. 666: Does ‘Floseal’ Topical Hemostatic Agent have an Adverse Effect on Prostatic Neurovascular Bundle Function?
45. 63: UTI After Successful Deflux Injection to Correct Vesicoureteral Reflux
46. 1794: Verification Bias in the Assessment of Prostate Specific Antigen (PSA) As a Screening Test for Prostate Cancer
47. 1700: The Repeatability of Urodynamic Findings in Healthy Female Volunteers: Results of Repeated Studies in the Same Setting and After Short-Term Follow-up
48. 1537: Relationship between Prostate-Specific Antigen (PSA) and Total Prostate Volume (TPV) in Japanese Men
49. 316: Risk Factors for Distant vs. Local Recurrence in Patients Undergoing Radical Cystectomy for Transitional Cell Cancer
50. 302: Lymphovascular Invasion Independently Predicts Increased Risk of Distant Recurrence and Decreased Overall Survival in Patients with Transitional Cell Carcinoma (TCC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.